TrialBlood2012

Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms.

Satoru Otsuru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.